Liquidia Corp (LQDA)
12.79
-0.19
(-1.46%)
USD |
NASDAQ |
May 03, 16:00
12.78
0.00 (0.00%)
After-Hours: 20:00
Liquidia Accounts Receivable (Quarterly): 4.061M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.061M |
September 30, 2023 | 3.338M |
June 30, 2023 | 4.095M |
March 31, 2023 | 4.131M |
December 31, 2022 | 5.017M |
September 30, 2022 | 3.136M |
June 30, 2022 | 3.753M |
March 31, 2022 | 3.287M |
December 31, 2021 | 2.99M |
September 30, 2021 | 3.050M |
June 30, 2021 | 2.992M |
March 31, 2021 | 0.6276M |
December 31, 2020 | 0.00 |
Date | Value |
---|---|
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | 0.9457M |
June 30, 2019 | 0.604M |
March 31, 2019 | 0.0105M |
December 31, 2018 | 0.2726M |
September 30, 2018 | 0.0819M |
June 30, 2018 | 0.0739M |
March 31, 2018 | 0.6174M |
December 31, 2017 | 1.622M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
5.017M
Maximum
Dec 2022
2.802M
Average
3.136M
Median
Sep 2022
Accounts Receivable (Quarterly) Benchmarks
United Therapeutics Corp | 307.30M |
AIM ImmunoTech Inc | -- |
Perspective Therapeutics Inc | 1.165M |
Protalix BioTherapeutics Inc | 5.272M |
Armata Pharmaceuticals Inc | -- |